Community-acquired methicillin-resistant Staphylococcus aureus in Switzerland : first surveillance report

C Aramburu; S Harbarth; N Liassine; M Girard; A Gervaix; J Scherenzel; G Renzi; P Sudre

doi:10.2807/esm.11.01.00594-en

Surveillance report Open Access

Like 0

This item has no PDF Download

Community-acquired methicillin-resistant Staphylococcus aureus in Switzerland : first surveillance report

C Aramburu^1,2, S Harbarth³, N Liassine⁴, M Girard², A Gervaix³, J Scherenzel³, G Renzi³, P Sudre²
View Affiliations Hide Affiliations

Affiliations: ¹ European Programme for Intervention Epidemiology Training, Geneva, Switzerland ² General Directorate of Health, Geneva, Switzerland ³ Hôpitaux universitaires de Genève, Switzerland ⁴ Bioanalytique-Riotton, Unilabs, Geneva, Switzerland

Correspondence:
View Citation Hide Citation

Citation style for this article: Aramburu C, Harbarth S, Liassine N, Girard M, Gervaix A, Scherenzel J, Renzi G, Sudre P. Community-acquired methicillin-resistant Staphylococcus aureus in Switzerland : first surveillance report. Euro Surveill. 2006;11(1):pii=594. https://doi.org/10.2807/esm.11.01.00594-en

Abstract

Methicillin resistant Staphylococcus Aureus (MRSA) infection is an emerging community pathogen. Community-acquired MRSA (CA-MRSA) has been associated with virulent strains producing Panton-Valentine leukocidin (PVL) and a variety of other exotoxins. In Geneva, PVL-producing CA-MRSA was first reported in 2002 and a surveillance system based on voluntary reporting was set up.